Ironwood Pharmaceuticals reported $395.85M in Debt for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Agios Pharmaceuticals AGIO:US USD 1.14M 84K
Akebia Therapeutics AKBA:US USD 65.95M 32.21M
Alnylam Pharmaceuticals ALNY:US USD 1.02B 338.25M
Ardelyx ARDX:US USD 26.54M 168K
Astellas Pharma 4503:JP JPY 288B 30.1B
Astrazeneca AZN:US USD 29.3B 229M
AstraZeneca AZN:LN USD 29.3B 229M
Charles River Laboratories CRL:US USD 2.94B 60.45M
Coherus Biosciences CHRS:US USD 245.25M 175.72M
Emergent Biosolutions EBS:US USD 1.05B 228.1M
Esperion Therapeutics ESPR:US USD 259.49M 407K
Exact Sciences EXAS:US USD 2.25B 2.88M
Halozyme Therapeutics HALO:US USD 1.5B 258.29M
Intercept Pharmaceuticals ICPT:US USD 332.31M 381.55M
Ironwood Pharmaceuticals IRWD:US USD 395.85M 399K
Karyopharm Therapeutics KPTI:US USD 302.89M 201K
Moderna Inc MRNA:US USD 1.15B 384M
Pacira Pharmaceuticals PCRX:US USD 747.87M 7.78M
Ptc Therapeutics PTCT:US USD 1.06B 145.39M
Puma Biotechnology PBYI:US USD 97.99M 312K
Sarepta Therapeutics SRPT:US USD 1.54B 441.9M
Takeda 4502:JP JPY 4.74T 134.39B